Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD4-positive helper T lymphocytes are a principal subset of T cells critical for the proper functioning of the adaptive immune system[1][2][3]. They are identified by the presence of CD4 on their surface, which serves as a coreceptor for the major histocompatibility complex class II (MHC-II) on antigen-presenting cells. Upon activation, CD4+ T cells differentiate into specialized subtypes including Th1, Th2, Th17, Treg, and Tfh cells, each with distinct cytokine profiles and immune functions[4][6]. These cells orchestrate immune responses by stimulating B cells for antibody production, activating cytotoxic T cells and macrophages, and regulating inflammatory processes. CD4+ T cell depletion, especially due to HIV infection, leads to severe immunodeficiency, making their enumeration and preservation a key focus in infectious disease therapy and monitoring[2][7]. Their dysregulation is implicated in autoimmunity, cancer, and exacerbated inflammatory responses[1][4][6].
Inhibition of viral entry or replication (ART drugs prevent HIV from infecting or destroying CD4+ T cells)[2] Suppression of immune function (immunosuppressants reduce T cell activation, cytokine production)[4] Modulation of cytokine signaling or subset differentiation (biologics target specific cytokines produced by T cell subsets)[4][6]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD4-positive helper T lymphocyte (CD4+ T cell).